medigraphic.com
ISSN 1561-2937 (Print)

2015, Number 1

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2015; 21 (1)

Primary prevention of the ischemic heart disease in the primary level. Annotations of interest

Ortega TYY, Armas RNB, Dueñas HA, de la Noval R, Acosta GM

Language: Spanish
References: 7
Page: 24-31
PDF size: 489.72 Kb.


ABSTRACT

Ischemic heart disease is related to lifestyle, especially snuff consumption, unhealthy eating habits, physical inactivity and psychosocial stress. There is general agreement that this disease is caused by multiple factors, some other congenital and acquired, which are harnessed together to damage the wall of the arteries. Therefore both primary, secondary and tertiary prevention of IHD is based on lifestyle change directed towards the elimination or reduction of risk factors and implementing control of cardiac disease to avoid complications and relapses for which presents a compendium of measures on lifestyle and healthy for the overall cardiovascular risk management and control recommendations of possible complications power.


REFERENCES

  1. World Health Organization. Joint WHO/FAO Expert Consul-tation on Diet, Nutrition and the Prevention of Chronic Dis-eases. 2002. Report No. 916.

  2. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endotheliumdependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998; 32:123-7.

  3. Diet, Physical Activity and Cardiovascular Disease Preven-tion in Europe. Bruselas: European Heart Network; 2011.

  4. Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2008; 15:239-46.

  5. Lollgen H, Bockenhoff A, Knapp G. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med. 2009; 30:213-24.

  6. Yamaguchi Y, Matsuno S, Kagota S, Haginaka J, Kunitomo M. Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits. Athero-sclerosis. 2001; 156:109-17.

  7. Zanchetti A, Grassi G, Mancia G. When should antihyperten-sive drug treatment be initiated and to what levels should sys-tolic blood pressure be lowered? A critical reappraisal. J Hy-pertens. 2009; 27:923-34.




2020     |     www.medigraphic.com